MNTX 302

· Bausch Health Americas, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MNTX 302, covering 2019-11-27 to 2019-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Treatment Extension of Protocol MNTX 302 [Phase 3]